Cargando…
Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence
The squamous cell carcinomas represent about 90 % of all head and neck cancers, ranking the sixth most common human cancer. Approximately 450,000 of new cases of head and neck squamous cell carcinoma (HNSCC) are diagnosed every year. Unfortunately, because of diagnosis at the advanced stages and ear...
Autores principales: | Zhi, Xu, Lamperska, Katarzyna, Golusinski, Paweł, Schork, Nicholas J., Luczewski, Lukasz, Kolenda, Tomasz, Golusinski, Wojciech, Masternak, Michal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381614/ https://www.ncbi.nlm.nih.gov/pubmed/25575813 |
Ejemplares similares
-
Circulating small non coding RNA signature in head and neck squamous cell carcinoma
por: Martinez, Berta Victoria, et al.
Publicado: (2015) -
The importance of stem cell engineering in head and neck oncology
por: Barczak, Wojciech, et al.
Publicado: (2016) -
Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma
por: Szewczyk, Mateusz P., et al.
Publicado: (2014) -
miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients
por: Piotrowski, Igor, et al.
Publicado: (2021) -
hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification
por: Barczak, Wojciech, et al.
Publicado: (2018)